Amturnide side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Death

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Drug ineffective
2. Blood pressure fluctuation
3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
4. Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
5. Dizziness
6. Heart rate increased
7. Joint injury
8. Plasma cell myeloma (cancer that begins in plasma cells)
9. Pruritus (severe itching of the skin)
10. Renal failure (kidney dysfunction)

female:

1. Blood pressure fluctuation
2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
3. Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
4. Dizziness
5. Heart rate increased
6. Joint injury
7. Plasma cell myeloma (cancer that begins in plasma cells)
8. Pruritus (severe itching of the skin)
9. Renal failure (kidney dysfunction)
10. Drug ineffective

male:

1. Death
2. Chest pain
3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
4. Foot deformity (functional disability of foot)
5. Drug ineffective

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

1. Death
2. Drug ineffective

60+:

1. Chest pain
2. Foot deformity (functional disability of foot)
3. Abdominal pain upper
4. Blindness
5. Blood pressure fluctuation
6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
7. Plasma cell myeloma (cancer that begins in plasma cells)